SELECTIVE PROTON COUPLED FOLATE TRANSPORTER AND FOLATE RECEPTOR, AND GARFTASE AND/OR OTHER FOLATE METABOLIZING ENZYMES INHIBITOR COMPOUNDS AND METHODS OF USING THE SAME
申请人:Gangjee Aleem
公开号:US20110082158A1
公开(公告)日:2011-04-07
Fused cyclic pyrimidine compounds, including tautomers thereof, and pharmaceutically acceptable salts, prodrugs, solvates and hydrates thereof, are disclosed having the general Formula II:
These compounds are useful in methods for treating cancer, selectively targeting cancerous cells via the proton coupled folate transporter, folate receptor alpha, and/or folate receptor beta pathways, inhibiting GARFTase and/or other folate metabolizing enzymes in cancerous cells, and selectively targeting activated macrophages in a patient having an autoimmune disease, such as rheumatoid arthritis.
本发明公开了融合的环状嘧啶化合物(包括其互变异构体)及其药学上可接受的盐、前药、溶剂化物和水合物,其具有通用式II:这些化合物在治疗癌症的方法中有用,通过质子耦合叶酸转运体、叶酸受体α和/或叶酸受体β途径选择性地靶向癌细胞,抑制癌细胞中的GARFT酶和/或其他叶酸代谢酶,并选择性地靶向患有自身免疫疾病(如类风湿性关节炎)的患者中的活化巨噬细胞。